Profile image for Simon Moulton

Professor Simon Moulton

Professor, Biomedical Electromaterials Science
PhD, University of Wollongong, Australia; Bachelor of Science (Honours), University of Wollongong, Australia; Bachelor of Technology: Environmental Geochemistry, Macquarie University, Australia


Prof Moulton obtained his PhD from the University of Wollongong (UoW) in 2002. His research lies at the intersection between chemical and materials engineering and medicine and is based on the principle of end-user driven design. He is a past recipient of the ARC Queen Elizabeth II Fellowship in 2009. Since 2005, he has attracted (leading teams as well as a team member) approximately $30million in category 1, 2 and 3 research funding. These grants include ARC Centre of Excellence, ARC Discovery, ARC Linkage, MRFF Commercialisation and philanthropic funding from Bill and Melinda Gates Foundation. These and other grants have facilitated his outstanding research track record and realised the establishment of one spin out company. Much of his non-commercially sensitive research outcomes have been published in high impact journals such as Biomaterials, Journal of American Chemical Society, ACS Nano, Advanced Functional Materials, Advanced Materials, Advanced Healthcare Materials, Carbon and Journal of Controlled Release.

Over the last 20 years Prof Moulton has developed vibrant and productive research teams across 2 Institutions (University of Wollongong and Swinburne University of Technology) working in materials and devices for medical solutions. His current team consists of 6 PhD students, 2 post doctorial fellows and 1 research assistant working in the areas of electrochemistry, advanced fabrication (3D printing), polymers, graphene, hydrogels, cellular biology and liposomes. He has developed strong research collaborations with medical clinicians and surgeons within large hospitals (St Vincent’s Hospital Melbourne and Alfred Hospital Melbourne) as well as medical research institutes (Peter MacCallum Cancer Centre, Bionics Institute, Burnet Institute and Baker Institute). These collaborations involve developing solutions for drug delivery for epilepsy, cancer and tissue engineering as well as engineering metal and carbon-based electrode-cellular interface platforms for nerve, muscle, and cartilage regeneration.

Research interests

Bioreactors and Tissue Engineering; Materials Science; Polymers at Interfaces; Biointerface Engineering

PhD candidate and honours supervision

Higher degrees by research

Accredited to supervise Masters & Doctoral students as Principal Supervisor.


Available to supervise honours students.

Fields of Research

  • Biomedical Engineering - 400300
  • Functional Materials - 401605
  • Electrochemistry - 340604

Teaching areas

Biomedical science;Materials Science


  • 2020, Swinburne, Certificate of School Reserach Excellence , Swinburne University of Technology, SSEE
  • 2019, Swinburne, Vice Chancellors’ 2019 Research Excellence Award, ARC Training Centre - Bioreactor, Swinburne University of Technology
  • 2018, Swinburne, Faculty of Science, Engineering and Technology Award: Nonconventional Transdisciplinary Research , Swinburne University of Technology
  • 2017, National, Vice Chancellor's Interdisciplinary Research Excellence Award, University of Wollongong
  • 2009, National, Vice Chancellor Award for Excellence: Emerging Researcher of the Year, University of Wollongong
  • 2009, National, ARC Queen Elizabeth II Fellowship, University of Wollongong
  • 2008, National, Australian Academy of Science European Travel Scholarship, Australian Academy of Science
  • 2007, National, Australian Academy of Science European Travel Scholarship, Australian Academy of Science
  • 2003, International, International Fellowship Trinity College Dublin, Ireland, Trinity College Dublin, Ireland


Also published as: Moulton, Simon; Moulton, S.; Moulton, S. E.; Moulton, Simon E.
This publication listing is provided by Swinburne Research Bank. If you are the owner of this profile, you can update your publications using our online form.

Recent research grants awarded

  • 2022: Cartilage based stem cell therapies for joint deformity and facial disfigurement. A framework for point-of-care manufacturing and delivery (ARISTOCRAT) *; MRFF Stem Cell Therapies Mission
  • 2022: Novel Approach for Immunotherapy Treatment of Pancreatic Cancer *; CASS Foundation Science and Medicine Grants
  • 2022: Processing and Modification of Short Polymer Fibres *; Cytomatrix Pty Ltd
  • 2021: Autologous Constructs for Muscle Engineering and Repair *; Ideas Grants
  • 2021: Cartilage Regeneration Program *; St Vincent’s Hospital
  • 2020: 3D Nanofabrication Facility *; ARC Linkage Infrastructure and Equipment Scheme
  • 2020: Development of lactic acid polymer coating for fabrication of multiple API delivery from over the counter intravaginal rings (OTC IVRs) *; Australian Centre for HIV and Hepatitis Virology Research (ACH2)
  • 2020: Exploring endophytes of traditional medicinal plants native to Australia: a potential source of novel bioactive compounds with medicinal, agricultural, and industrial applications. *; Commonwealth Scientific & Industrial Research Organisation (CSIRO)
  • 2020: Low-cost sensors for water quality control *; Victorian Government Memorandum of Understanding between Victoria and Paraná, Brazil
  • 2019: Advancement of Bioengineered Materials for Medicine: Strengthening the Australia-Korea Alliance *; DFAT Australia Korea Foundation
  • 2019: Cartilage Regeneration Program *; St Vincent’s Private Hospital Fitzroy
  • 2019: Development of hydrogel based intravaginal drug delivery device *; Victorian Medical Research Acceleration Fund
  • 2019: Development of hydrogel based intravaginal ring (IVR) drug delivery device (Student) *; Burnet Institute
  • 2019: Implantable drug-eluting device: localised drug delivery for non-resectable pancreatic cancer *; Priority-driven Collaborative Cancer Research Schem
  • 2019: Investigation of the interplay between blood cells and the endothelium in microfluidic devices *; Australian Mathematical Sciences Institute Intern Program
  • 2019: The EVE-M Initiative - Enhancing the Vaginal Environment and Microbiome *; Frontier Health and Medical Research Program
  • 2019: The EVE-M Initiative - Enhancing the Vaginal Environment and Microbiome *; Frontier Health and Medical Research Program
  • 2018: BioPen: Development of the First In-Situ Bioprinting Treatment for Cartilage Injuries *; MTPConnect BioMedTech Horizons
  • 2018: Develop Injectable microparticles capable of targeting specific vascular blockages then provide therapeutic stabilisation or eradication through triggered release of encapsulated therapeutics *; Baker IDI Heart and Diabetes Institute
  • 2018: Targeting cervicovaginal inflammation to prevent HIV transmission *; Burnet Institute
  • 2018: Tough hydrogel materials as drug delivery vehicles for prevention and treatment of HIV and other sexually transmitted infections *; Australian Centre for HIV and Hepatitis Virology Research (ACH2)
  • 2018: Ultra-low fouling active surfaces *; ARC Discovery Projects Scheme
  • 2017: Textured Nanostructured based devices for energy and sensing applications *; Swinburne and FAPESP Priority Partnership Fund
  • 2016: ARC Centre of Excellence for Electromagnetic Science (ACES) *; ARC Centre of Excellence Scheme
  • 2016: Project Geldom Phase II *; Bill and Melinda Gates Foundation
  • 2010: Field-emission gun transmission electron microscope for the research in nanomaterials, metal alloys and biological sciences *; ARC Linkage Infrastructure and Equipment Scheme

* Chief Investigator

Recent media

There are no media items to display